Not all patients with CLL have to have therapy. In spite of all the latest developments, the iwCLL continue to recommends watchful observation for clients with asymptomatic ailment.86 This recommendation is based on not less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituxi